Industry NewsLife Sciences QIAGEN expands portfolio for minimal residual disease testing in oncology with new strategic partnerships
Product NewsClinical Diagnostics Sequenta Collaborators to Present Five Studies Showing the Power of LymphoSIGHT Minimal Residual Disease Platform at EHA
